Dataset Information

Facebook and the Covid-19 Crisis: Building Solidarity Through Community Feeling

ABSTRACT: In the event of the Covid-19 spread, the entire world has been brought to a stop due to the imposed lockdown, to counter the effects of the spreading virus. This paper proposes to study the change in how people are experiencing a pandemic very differently and what such changes imply with respect to social connections and human interactions. The networked digital citizens come together in the time of crisis, sharing a sense of nostalgia as well as perseverance on Facebook. The paper will refer to Maslow’s Hierarchy of Needs in order to explain the human need for the sense of belonging. A pandemic has not been experienced in earlier time as a global phenomenon with far reaching consequences as in the present context. People across the world are experiencing a similar form of loneliness, boredom, and anxiety irrespective of which profession one belongs to. The absence of physical movement has suddenly caused a great shift of interaction on to the Facebook platform. The corner stone for virtual social interaction had already been laid down with the rise of a ‘convergence culture’. Social communities depicting shared interests like music, dance, photography, food, and other aspects of life have been redesigned and restructured as a result of the lockdown. More and more people are sharing videos of activities they are engaging in during this time of immobility. A greater focus of family experiences are being shared by celebrities, creating a semblance of solidarity in fighting against the psychological effects of a long term lockdown. The provision of the care button on Facebook also intensifies this sense of a shared trauma and the human desire to overcome all hurdles together. The paper will focus on a number of Facebook trends, beginning from Dalgona coffee and its perception to music covers of popular songs such as ‘Dance Monkey’ and Bella Ciao. The historical meaning associated with the term ‘crisis’ is being redefined in a social context which greatly based on a networked population. This has an entirely different social and psychological implication. Analysing the Facebook updates will go a long way in understanding the term ‘crisis’ with respect to the time of Corona.

SUBMITTER: Nandy R

PROVIDER: S-EPMC7816138 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundWorld Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with coronavirus disease 2019 (Covid-19).MethodsWe randomly assigned inpatients with Covid-19 equally between one of the trial drug regimens that was locally available and open control (up to five options, four active and the local standard of care). The intention-to-treat primary analyses examined in-hospital mortality in the four pairwise comparisons of each trial drug and its control (drug available but patient assigned to the same care without that drug). Rate ratios for death were calculated with stratification according to age and status regarding mechanical ventilation at trial entry.ResultsAt 405 hospitals in 30 countries, 11,330 adults underwent randomization; 2750 were assigned to receive remdesivir, 954 to hydroxychloroquine, 1411 to lopinavir (without interferon), 2063 to interferon (including 651 to interferon plus lopinavir), and 4088 to no trial drug. Adherence was 94 to 96% midway through treatment, with 2 to 6% crossover. In total, 1253 deaths were reported (median day of death, day 8; interquartile range, 4 to 14). The Kaplan-Meier 28-day mortality was 11.8% (39.0% if the patient was already receiving ventilation at randomization and 9.5% otherwise). Death occurred in 301 of 2743 patients receiving remdesivir and in 303 of 2708 receiving its control (rate ratio, 0.95; 95% confidence interval [CI], 0.81 to 1.11; P = 0.50), in 104 of 947 patients receiving hydroxychloroquine and in 84 of 906 receiving its control (rate ratio, 1.19; 95% CI, 0.89 to 1.59; P = 0.23), in 148 of 1399 patients receiving lopinavir and in 146 of 1372 receiving its control (rate ratio, 1.00; 95% CI, 0.79 to 1.25; P = 0.97), and in 243 of 2050 patients receiving interferon and in 216 of 2050 receiving its control (rate ratio, 1.16; 95% CI, 0.96 to 1.39; P = 0.11). No drug definitely reduced mortality, overall or in any subgroup, or reduced initiation of ventilation or hospitalization duration.ConclusionsThese remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay. (Funded by the World Health Organization; ISRCTN Registry number, ISRCTN83971151; ClinicalTrials.gov number, NCT04315948.).

Dataset Information

Facebook and the Covid-19 Crisis: Building Solidarity Through Community Feeling

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure